["{\n\"step_by_step_thinking\": \"The patient has sickle cell anemia, which is a hemolytic disorder. Sickle cell anemia is associated with a higher risk of venous thromboembolism. The DVT prophylaxis is aimed at preventing deep vein thrombosis. A normal prothrombin time (PT) and elevated partial thromboplastin time (PTT) suggest that the patient has an intrinsic coagulopathy, rather than a deficiency in one of the clotting factors. Therefore, the most directly affected factor by the DVT prophylaxis would be the one involved in the intrinsic pathway of coagulation.\",\n\"answer_choice\": \"D: XII\"\n}"]